In this issue:
Early remdesivir to prevent progression to severe COVID-19
Molnupiravir for oral treatment of COVID-19
Protection against COVID-19 by BNT162b2 booster across age groups
Early assessment of the clinical severity of the SARS-CoV-2 Omicron variant
Nasal prevention of SARS-CoV-2 infection
Characteristics, outcomes, and severity risk factors in children
Community transmission and viral load kinetics of the Delta variant
Long-term cardiovascular outcomes of COVID-19
Resistance mutations after sotrovimab use
Fragility of statistically significant results
Please login below to download this issue (PDF)